These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

475 related items for PubMed ID: 27127133

  • 1. Syndecan-1, Epithelial-Mesenchymal Transition Markers (E-cadherin/β-catenin) and Neoangiogenesis-related Proteins (PCAM-1 and Endoglin) in Colorectal Cancer.
    Mitselou A, Galani V, Skoufi U, Arvanitis DL, Lampri E, Ioachim E.
    Anticancer Res; 2016 May; 36(5):2271-80. PubMed ID: 27127133
    [Abstract] [Full Text] [Related]

  • 2. The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and beta-catenin, in prostate cancer.
    Contreras HR, Ledezma RA, Vergara J, Cifuentes F, Barra C, Cabello P, Gallegos I, Morales B, Huidobro C, Castellón EA.
    Urol Oncol; 2010 May; 28(5):534-40. PubMed ID: 19450993
    [Abstract] [Full Text] [Related]

  • 3. The role of biological markers of epithelial to mesenchymal transition in oesophageal adenocarcinoma, an immunohistochemical study.
    Prins MJ, Ruurda JP, Lolkema MP, Sitarz R, Ten Kate FJ, van Hillegersberg R.
    J Clin Pathol; 2015 Jul; 68(7):529-35. PubMed ID: 25855799
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Overexpression of homeobox B-13 correlates with angiogenesis, aberrant expression of EMT markers, aggressive characteristics and poor prognosis in pancreatic carcinoma.
    Zhai LL, Wu Y, Cai CY, Tang ZG.
    Int J Clin Exp Pathol; 2015 Jul; 8(6):6919-27. PubMed ID: 26261579
    [Abstract] [Full Text] [Related]

  • 13. Expression of epithelial-mesenchymal transition and cancer stem cell markers in colorectal adenocarcinoma: Clinicopathological significance.
    Choi JE, Bae JS, Kang MJ, Chung MJ, Jang KY, Park HS, Moon WS.
    Oncol Rep; 2017 Sep; 38(3):1695-1705. PubMed ID: 28677737
    [Abstract] [Full Text] [Related]

  • 14. ILEI: a novel marker for epithelial-mesenchymal transition and poor prognosis in colorectal cancer.
    Gao ZH, Lu C, Wang ZN, Song YX, Zhu JL, Gao P, Sun JX, Chen XW, Wang MX, Dong YL, Xu HM.
    Histopathology; 2014 Oct; 65(4):527-38. PubMed ID: 24738665
    [Abstract] [Full Text] [Related]

  • 15. Immunohistochemical study of E-cadherin and β-catenin expression in colorectal carcinomas.
    Ozgüven BY, Karaçetin D, Kabukçuoğlu F, Taşkin T, Yener Ş.
    Pol J Pathol; 2011 Oct; 62(1):19-24. PubMed ID: 21574102
    [Abstract] [Full Text] [Related]

  • 16. Aberrant expression of β-catenin and E-cadherin is correlated with poor prognosis of nasopharyngeal cancer.
    Xu L, Jiang Y, Zheng J, Xie G, Li J, Shi L, Fan S.
    Hum Pathol; 2013 Jul; 44(7):1357-64. PubMed ID: 23375645
    [Abstract] [Full Text] [Related]

  • 17. PDLIM1 Stabilizes the E-Cadherin/β-Catenin Complex to Prevent Epithelial-Mesenchymal Transition and Metastatic Potential of Colorectal Cancer Cells.
    Chen HN, Yuan K, Xie N, Wang K, Huang Z, Chen Y, Dou Q, Wu M, Nice EC, Zhou ZG, Huang C.
    Cancer Res; 2016 Mar 01; 76(5):1122-34. PubMed ID: 26701804
    [Abstract] [Full Text] [Related]

  • 18. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
    Kim YT, Choi EK, Kim JW, Kim DK, Kim SH, Yang WI.
    Yonsei Med J; 2002 Dec 01; 43(6):701-11. PubMed ID: 12497652
    [Abstract] [Full Text] [Related]

  • 19. Loss of E-Cadherin expression is associated with a poor prognosis in stage III colorectal cancer.
    Yun JA, Kim SH, Hong HK, Yun SH, Kim HC, Chun HK, Cho YB, Lee WY.
    Oncology; 2014 Dec 01; 86(5-6):318-28. PubMed ID: 24924873
    [Abstract] [Full Text] [Related]

  • 20. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.
    Choi YS, Shim YM, Kim SH, Son DS, Lee HS, Kim GY, Han J, Kim J.
    Eur J Cardiothorac Surg; 2003 Sep 01; 24(3):441-9. PubMed ID: 12965318
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.